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Abstract: A neutral octahedral mononuclear iron(II) tetrabromide complex, [Fe(Hampy)2Br4], that 
consists of equatorial bromide and protonated aminopyrazinium axial ligands is successfully 
synthesised through redox chemistry and analysed using X-ray crystallography. The iron(II) oxidation 
state is balanced by the protonated pyrazinium nitrogen just outside the coordination sphere. The 
biological properties of this and two other related complexes are investigated using both Gram-
negative and Gram-positive bacteria as well as methicillin resistant strains. They all exhibit some 
antimicrobial properties albeit at moderate to poor concentrations. However, the tetrahalide 
complexes analysed exhibit excellent anti biofilm properties well below cytotoxic levels.  
 







Tetrachloroferrates and tetrabromoferrates have been utilised in many areas of materials 
chemistry for their easy synthesis and magnetic properties.[1–4] They have been widely used 
in areas such as functional ionic liquid synthesis,[5–7] and catalysis.[8,9] Most examples are 
trivalent and are balanced by either group 1 or 2 metals or simple positively charged nitrogen 
species, e.g. ammonium, pyridinium, imidazolium.[10–13] 
In our previous work, we synthesised an octahedral Fe(II) complex that consisted of four 
equatorial chloride ligands with two axial aminopyrazinium ligands, [Fe(II)Cl4(HAmpy)2], 
complex 1.[14] Searching the Cambridge Structural Database (CSD)[15] reveals that the 
complex, Fe(II)Cl4(HAmpy)2, is the only example of a mononuclear octahedral tetrahalide iron 
derivative where the balancing charges are on the same molecule rather than an exogenous 
spectator cation. There are numerous examples of iron species with several chloride ligands; 
however, they are predominantly polymeric in nature and/or have exogenous cations to balance 
charge.  
In this work, we wanted to expand the tetrahalide motif to bromide ligands. A search of the CSD 
reveals there are only six examples of an octahedral Fe complex with four bromide ligands with 
a published structure. Of these six structures, three are discrete multinuclear clusters. The first, 
an undecanuclear mixed metal cluster containing iron, gallium and potassium bridged by 
bromides, by Linti et al.[16] Here the central iron is coordinated to four bromides with the axial 
positions being occupied by bridging oxides. The second is a trinuclear iron cluster with bridging 
bromide ligands with β‐diketiminate terminal ligands  by Jones et al.[17] The third example is a 
mixed trinuclear cluster with a central iron ion coordinated to four bridging bromides that 
coordinate a zinc ion capped by THF and p-tolyl groups by Bedford et al.[18] In these examples 
all the bromide ligands coordinated to iron are bridging and therefore do not constitute a formally 
tetra anionic metal centre as seen in Fe(II)Cl4(HAmpy)2. The other three examples are polymeric 
in nature; the first example from Reiff et al. is a catena-bridged ferrous bromide derivative with 
water molecules in the axial positions.[19] Work by Schmidt et al. utilising cyanopyridine forms 
polymeric chains of iron bromide units where there are two possible motifs,[20,21] one where 
the bridging equatorial bromides are the linkers and the other where there is both the bridging 
bromides as well as coordination at the cyanide nitrogen. All three polymeric examples contain 
the iron centre with equatorial bromides with a differing axial ligand. However, none of these 
examples possess the tetra anionic ligand set found in our previous work.  
This work presents the synthesis of [Fe(Hampy)2Br4], complex 2, using the same redox-based 
synthesis found in our previous work, wherein the oxidation of salicylaldehyde is facilitated by 
the reduction of ferric bromide to a ferrous salt resulting in the isolation of 2, figure 1. We also 
present the ferric complex, [Fe(bipy)(Sal)Cl2]·CH3CN, complex 3, that results from the addition 
of 2,2’-bipyridine to the synthesis of 1. This seemingly stops the redox process and stabilises 
the ferric chloride. We present the potential for antimicrobial effects along with the key structural 
features of the novel complexes.  
 
 
Figure 1: Structure of the iron halide complexes 1, 2, and 3. 
 
 
Results and Discussion 
Structural analysis of complexes 2 and 3 
 
Complex 2 results from the modified synthesis previously reported for complex 1. The structural 
motif is identical to that of complex 1. 2 also sits on a crystallographic centre of symmetry 
resulting only 3 unique metal-ligand bond lengths. The use of ferric bromide rather than chloride 
results in an iron (II) species with equatorial bromide ligands balanced by aminopyrazinium 
ligands in the axial positions (Figure 2A). As discussed previously, the complex is the result of 
a redox couple between the Fe(III) species and the aldehyde used in the synthesis. It is a 
formally tetra anionic equatorial ligand set balanced by the pyrazinium nitrogen just outside the 
immediate coordination sphere.  
 
Complex 3 results from the competitive addition of a co-ligand to the mixture containing the 
ferric chloride iron source. The addition of the bipyridine ligand inhibits the redox chemistry and 
forms a more straightforward Fe (III) complex containing one bidentate coordinated bipyridine, 
two chloride ligands and finally, one salicylaldehyde coordinated through the aldehyde lone pair 
and a deprotonated phenolate oxygen, as shown in Figure 2B.  
 
The metal-ligand bond lengths in each complex indicate a high spin ion S = 2 for 2, S = 5/2 for 




Figure 2: A) Structure of complex 2 at 150 K; B) Structure of complex 3 at 150 K, 
solvent removed for clarity. 
. Table 1: Bond lengths for complexes 2 and 3 at 150 K. 
Complex 2 Å Complex 3 Å 
Fe-N1 2.233(3) Fe-N1 2.170(3) 
Fe-Br1 2.6267(9) Fe-N2 2.191(3) 
Fe-Br2 2.6192(9) Fe-O1 1.917(2) 
  Fe-O2 2.101(2) 
  Fe-Cl1 2.3117(9) 
  Fe-Cl2 2.2894(9) 
 
Complex 2 is isostructural to the previously published complex 1.[14] The same hydrogen-
halogen bonding 3-D architecture is present throughout the lattice with the hydrogen on the 
pyrazine nitrogen and the amine interacting with the bromide ligands of neighbouring 
complexes. Here longer contacts are observed between the donor and acceptor due to the 
larger atomic radius of bromine versus chlorine. There are two major motifs of non-covalent 
interactions in 2. One, where a 2-D sheet is formed, Figure 3, this occurs between the 
hydrogens on both the amine and protonated pyrazinium moieties, and the bromide ligands of 
two neighbouring complexes. The length of these interactions, Br-H(N) 2.78-2.91 Å, falls within 
accepted lengths.[25] The second motif is the non-covalent “stitching” together of these 2-D 
sheets. There is a shorter Br-H(N) interaction, 2.46 Å, between each sheet.  
Complex 3 exhibits only small π-π overlap between the bipyridine ligands over neighbouring 
complexes forming pseudo-dimers, Figure 4. The C-C intermolecular contact distances are ca. 
3.4 Å and the rings are coplanar. 
 
 
Figure 3: Hydrogen-halogen interactions between neighbouring complexes in complex 2. 
Hydrogen bonding in blue. 
 
Figure 4: π-π dimers in complex 3. Hydrogen bonding in blue. 
Biological Properties Analysis 
Multidrug resistance is becoming a major worldwide problem. As such, many metal complexes 
are being looked at as potential antimicrobials.[26] The study by Frei et al. exhibits that a very 
low number of iron complexes meet the criteria of being active and non-toxic. We have 
therefore investigated the antimicrobial and cytotoxicity of complexes 1-3. The bacterial strains 
used in these studies were the methicillin-resistant Staphylococcus aureus NCTC 12493, 
Pseudomonas aeruginosa strain PAO1 and Escherichia coli NCTC 10418. (For full details on 
methods used please see the supporting information.) 
Well-diffusion tests, using complexes 1-3, were performed to investigate any possible 
inhibitory effect on bacterial cell growth. The results of this experiment indicated that the three 
iron halide complexes and their FeCl3 and FeBr3 precursor metal salts inhibited bacterial cell 
growth, while 2-aminopyrazine did not, Figure S1. The complex zone of inhibition ranged from 
15 to 25 mm. However, high concentrations were needed to observe inhibition of bacterial 
growth. Therefore, agar dilution tests using complexes 1-3 were performed to determine the 
lowest concentration at which complexes prevented bacterial cell growth. The experimental 
findings showed that the minimal inhibitory concentration (MIC) of complexes 1 and 2 were 5 
mM and 3.5 mM, respectively. However, the MIC value of complex 3 was 10 mM for MRSA 
and P. aeruginosa, whereas in the E. coli experiment it was 4-fold higher, at 40 mM, Table 2. 
A time-kill experiment was next performed to evaluate the anti-microbial activity of the iron 
halides over time, Figure S2. The result of the study indicated a bactericidal mode of action of 
the novel-iron complexes as they caused a three times log reduction of the CFU/mL.[27] This 
bactericidal mode of action was also suggested by the increase amount of extracellular DNA 
associated to bacterial strains exposed to the iron-halide complexes, Figure S2.D.  
 
Table 2. Minimal inhibitory concentration of the iron halide complexes and their ligands. 
        Minimal inhibitory concentration (mM) 
 1 2 3 FeCl3 FeBr3 
MRSA  5±0.21 3.5±0.01 10±0.35 24±0.35 1.2±0.01 
P. aeruginosa  5±0.11 3.5±0.21 10±0.22 12±0.55 1.2±0.02 
E. coli  5±0.22 3.5±0.02 40±0.56 25±0.22 1.2±0.11 
5x105 CFU/mL bacteria suspensions were incubated with different concentrations of the iron complexes and their metal 
precursors. MIC was defined as the minimal concentration where ≥99.9 % bacteria death of initial inoculum was observed. 
Data represents three independent measurements (means ± SEM). Abbreviation: MRSA, methicillin-resistant 
Staphylococcus aureus. 
The cytotoxic properties were investigated by Alamar Blue assays and MTT assays, Figure 
S3. The MTT reduction assay was first used to study the in vitro effects of the iron complexes 
on the viability of the HaCaT cell line. The main results from the MTT assay were that 1 and 2 
exhibited non-cytotoxic behaviour at concentrations of 1 mM and below, with 3 at 
concentrations of 0.2 mM and below. This could be ascribed to the difference in oxidation 
state and/or ligand environment. The Alamar Blue assays agreed with the MTT results. 
However, 1 and 2 exhibited some slight decrease in cell viability at 1 mM concentrations.  
The last investigation that was performed was the effect of complexes 1-3 on the formation 
and reduction of MRSA biofilms. Biofilms, which are self-produced matrices of extracellular 
polymeric substances that aid in strengthening microorganisms to external stresses including 
antimicrobial agents, are an important mechanism for MRSA to adhere to both living and non-
living materials.[28,29] Only in the last couple of decades has the predominant life-mode of 
most bacterial species been realized to be biofilm growth. Therefore, interference with this 
mechanism can aid in synergistic treatment of resistant strains in high risk settings. Here we 
investigated the effect of 1-3 on both the formation of biofilms from MRSA and the reduction of 
formed biofilms, Figure 5. An inhibition of biofilm formation can be observed with complex 1 
and 2 at concentrations lower than 1 mM. This trend continues when reduction of premade 
biofilms is investigated, with complex 1 and 2 being able to reduce the biofilm present at 
concentrations less than 1 mM. Complex 3 requires far higher concentrations to exhibit a 
relatively weak change in both inhibition and reduction of biofilms. These values are of interest 
for 1 and 2 as they are below cytotoxic levels as observed in the MTT and Alamar Blue 
assays.  Iron salts are not unknown to affect the biofilm production in bacteria with several 
examples using basic iron salts exhibiting a reduction in biofilm production. The concentrations 
of iron sources range from low µM to mM.[30–32] However, there is no route to further 
derivatisation or functionalisation with these simple iron salts and not all examples exhibit an 
effect against resistant strains. Several examples of the use of iron oxide nanoparticles as an 
effective anti-biofilm agent have been published but the route for derivation is to change the 
periphery so it acts more as a delivery system rather than a chemical agent.[33–35] Research 
has been conducted into the role of iron and other metal in the production of biofilms, and it 
has been determined that iron plays a very important role with iron scavengers inhibiting 
biofilm formation also.[36–38] 
Figure 5: Anti-biofilm activity of the iron halide complexes. A), B) and C): Prevention of bacteria biofilm – the 
MRSA strains grown in a 96-wells plate were co-incubated with different concentrations of the iron complexes at 
37 ̊ C for 24 hours. Crystal violet staining of the cells attached to the bottom of the plate was followed by 
solubilisation of the dye and optical density measurement at 570 nm. D), E) and F): Biofilm dispersal – pre-
formed biofilms of the MRSA strain were incubated at 37 ̊ C for 24 hours with RPMI media containing different 
concentrations of the iron halide compounds (≤ MIC). Removal of the medium was then followed by crystal violet 
staining, dye solubilisation and optical density measurement at 570nm. Data were analysed statistically by one-
way ANOVA. The graph represents the average absorbance of the crystal violet-stained biofilms formed on 
microtiter well plates. ** P<0.001 versus control. 
The inhibition of biofilm formation and the disintegration of preformed biof ilms point 
toward a possible multimodal action of the complexes. The initial inhibition of 
formation can come from inhibition of bacterial surface adhesion or interfering with 
the quorum sensing system of the bacteria.[39,40] Complexes 1 and 2 may aid in 
this due to supramolecular interactions with the media or the bacteria cells 
themselves. Other modes of inhibition and degradation come from alterations to the 
genetic expression of the bacteria and changes in enzymatic processes, most 
notably, the bacterial second messenger bis-(3′-5′)-cyclic diguanosine 
monophosphate (c-di-GMP) involving diguanylate cyclases and specific 
phosphodiesterases.[41] The mode of action and mechanisms in biofilm inhibition 
caused by compounds 1 and 2 are complex areas to understand and will be a main 
aim for further studies.  
Conclusion 
In conclusion, we have added to the octahedral tetrabromide family of complexes. To 
the best of our knowledge we have synthesised the second example of a tetra anionic 
ligand set around a ferrous ion that is balanced by internal positive charges on the 
molecule rather than an exogenous cation. The effect of addition of co-ligands was 
observed in complex 3 where the co-ligand inhibited the redox synthesis observed in 
1 and 2. The change in oxidation and coordination environment has a large impact on 
the supramolecular properties of the complex. The intricate 3-D architecture found in 
the tetrahalide systems is lost and replaced with a weak π-π interaction. This is an 
area for exploration to expand the set of complexes available further by changing the 
redox couple and/or possible co-ligand. We have also investigated the biological 
properties of the complexes from our previous work and the novel complexes in this 
work. While the concentrations needed to observe antimicrobial properties are 
relatively high compared to commercially available antimicrobials, the anti-biofilm 
properties show promise as they are below the cytotoxic levels and in the 400-600 µM 
range for 1 and 2. This result gives rise to potential for a scaffold, with which further 
derivation could yield promising results for synergistic external control of bacterial 
infection.   
Experimental Section 
Synthesis of the Fe halide complexes 
Synthesis of Complex 1, [Fe(Hampy)2Cl4], was performed according to our previous 
work.[14] 
Synthesis of Complex 2, [Fe(Hampy)2Br4], was adapted from complex 1: 2-
aminopyrazine (0.095 g, 1.00 mmol) was added to salicylaldehyde (0.105 mL, 1.00 
mmol) in 1:1 methanol/acetonitrile (15 mL). Ferric bromide (0.400 g, 1.35 mmol) was 
added to the solution, initially resulting in a red colour, which later became dark purple. 
This mixture was then filtered after a further 10 min of stirring. Upon evaporation of the 
solvent, dark purple crystals were isolated and washed in acetone. Yield: 0.1839 g, 
32 %. IR: ʋmax (neat) / cm-1 3306, 3088, 1649, 1620, 770, 706. Elemental, Theory 
(Found): C 16.19(16.23), H 1.78(1.84), N 14.86(14.88). 
Alternative synthesis routes of both complexes 1 and 2 have been attempted to date, 
unsuccessfully. The use of ferrous starting salts does not yield 1 or 2. Further 
derivation by anion metathesis to exchange the chloride ligands has proven 
challenging to date and work is ongoing in this area.  
Synthesis of Complex 3, [Fe(bipy)(Sal)Cl2]·CH3CN: 2-aminopyrazine (0.095 g, 1.00 
mmol) was added to salicylaldehyde (0.122 g, 1.00 mmol) in 1:1 methanol/acetonitrile 
(15 mL) and stirred for 10 min. Ferric chloride hydrate (0.541 g, 2.00 mmol) was then 
added to this solution, resulting in a dark red colour, immediately followed by the 
addition of 2,2´-bipyridyl (0.156 g, 1.00 mmol). The solution was filtered after 20 min 
stirring and small, dark red plate-like crystals formed after several days of slow solvent 
evaporation. Yield: 0.2589 g. IR: ʋmax (neat) / cm-1 3304, 3051, 1655, 1620, 773, 678. 
Elemental, Theory (Found): C 51.27(50.95), H 3.62(3.39), N 9.44(7.55). The elemental 
analysis for complex 3 shows there is loss of solvation between isolation and analysis. 
The values for the non-solvated complex are C, 50.53; H, 3.24; N 6.93. The elemental 
analysis found for complex 3 exhibits approximately 0.35 CH3CN in the sample.  
Notes 
CCDC 1983590 and 1953591 contains the supplementary crystallographic data for 
complexes 2 and 3, respectively. These data can be obtained free of charge via 
https://www.ccdc.cam.ac.uk/structures/, or from the Cambridge Crystallographic Data 
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; or e-mail: 
deposit@ccdc.cam.ac.uk. 
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